Outcomes Associated with Sodium-Glucose Cotransporter-2 Inhibitor Use in Acute Heart Failure Hospitalizations Complicated by Acute Kidney Injury.

Abinet M Aklilu Sanchit Kumar Yu Yamamoto Dennis G Moledina Frederick SinhaJeffrey M TestaniFrancis Perry Wilson

Published in: Kidney360 (2023)

In adults experiencing AHF-associated AKI, exposure to SGLT2i was associated with decreased mortality and no delay in renal recovery. Prospective studies are needed to elucidate the impact of SGLT2i exposure during AKI, particularly during heart failure hospitalizations.

Keyphrases

acute heart failure
heart failure
acute kidney injury
cardiovascular events
risk factors
left ventricular
case control
cardiac resynchronization therapy
cardiovascular disease
atrial fibrillation
type diabetes
adipose tissue
metabolic syndrome
weight loss
glycemic control